EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trials and tribulations of overcoming xenograft rejection

Muhammad M Mohiuddin

Journal of the Pakistan Medical Association · 01.10.2025 · 75 (10 (Supp-3))

DOI: 10.47391/jpma.duhs-25-01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 01.10.2025. Verfasst von Muhammad M Mohiuddin. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Throughout the world, there are millions of patients with terminal organ failure who are waiting for a human organ for transplantation. Over the last 20 years, due to improvement in our understanding of transplant organ rejection and progressively improved immunosuppression regimens, organ transplants have provided a significant extension of life. This success has saved many lives, but at the same time, due to increased public awareness and demand, it has created an acute shortage of organ donors.1 Not every donor organ can be used for transplantation, and multiple factors contribute to the selection of a transplantable organ based on the stringent selection criteria of these donors and the organs. Therefore, a similar tough criterion is applied to the recipients based on the urgency of the organ requirement. Continued...

Zitieren

APA

Mohiuddin, M. M. (2025). Trials and tribulations of overcoming xenograft rejection. Journal of the Pakistan Medical Association, 75(10 (Supp-3)). https://doi.org/10.47391/jpma.duhs-25-01

Vancouver

Mohiuddin MM. Trials and tribulations of overcoming xenograft rejection. Journal of the Pakistan Medical Association. 2025;75(10 (Supp-3)). doi:10.47391/jpma.duhs-25-01

BibTeX
@article{Mohiuddin2025,
  author = {Mohiuddin, Muhammad M},
  title = {Trials and tribulations of overcoming xenograft rejection},
  journal = {Journal of the Pakistan Medical Association},
  year = {2025},
  volume = {75},
  number = {10 (Supp-3)},
  doi = {10.47391/jpma.duhs-25-01}
}
Kostenlos starten →